Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Rhabdomyosarcoma

(2019) Stephen X. Skapek et al.   Nature Reviews Disease Primers

A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations

(2019) Sally L. George et al.   EUROPEAN JOURNAL OF CANCER

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

(2019) Gianni Bisogno et al.   LANCET ONCOLOGY

Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group

(2019) Emily Hibbitts et al.   Cancer Medicine

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma

(2019) Dana L Casey et al.   CLINICAL CANCER RESEARCH

Current and Future Treatment Strategies for Rhabdomyosarcoma

(2019) Celine Chen et al.   Frontiers in Oncology

MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification

(2018) Narasimhan P. Agaram et al.   MODERN PATHOLOGY

tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish

(2018) Myron S Ignatius et al.   eLife

Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours

(2017) Elisa Izquierdo et al.   Oncotarget

Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma

(2016) Katherine M. Robbins et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research

(2016) W. Chang et al.   CLINICAL CANCER RESEARCH

Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials

(2016) Joanna Selfe et al.   PEDIATRIC BLOOD & CANCER

CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing

(2016) Eric Talevich et al.   PLoS Computational Biology

Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma

(2015) Masafumi Seki et al.   Nature Communications

Clonality and Evolutionary History of Rhabdomyosarcoma

(2015) Li Chen et al.   PLoS Genetics

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations

(2014) Shinji Kohsaka et al.   NATURE GENETICS

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

(2014) J. F. Shern et al.   Cancer Discovery

Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma

(2013) Xiang Chen et al.   CANCER CELL

Transactivating mutation of theMYOD1gene is a frequent event in adult spindle cell rhabdomyosarcoma

(2013) Karoly Szuhai et al.   JOURNAL OF PATHOLOGY

PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report

(2013) Stephen X. Skapek et al.   PEDIATRIC BLOOD & CANCER

Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study

(2012) Odile Oberlin et al.   JOURNAL OF CLINICAL ONCOLOGY

PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

(2012) Edoardo Missiaglia et al.   JOURNAL OF CLINICAL ONCOLOGY

Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

(2012) Suman Malempati et al.   PEDIATRIC BLOOD & CANCER

Rhabdomyosarcoma in infants younger than 1 year

(2011) Suman Malempati et al.   CANCER

Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations

(2011) Louis P Dehner et al.   MODERN PATHOLOGY

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

(2009) Simona Ognjanovic et al.   CANCER

Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group

(2009) Frederic G. Barr et al.   GENES CHROMOSOMES & CANCER

Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

(2008) Odile Oberlin et al.   JOURNAL OF CLINICAL ONCOLOGY